Risk of bleeding and stroke with oral anticoagulation and antiplatelet therapy in patients with atrial fibrillation in Taiwan: a nationwide cohort study.
<h4>Background</h4>Data on the use of oral anticoagulation (OAC) and antiplatelet therapy and the risk of bleeding and stroke amongst Asian patients with atrial fibrillation (AF) are limited. We investigated the risks of bleeding and stroke with use of oral anticoagulation (OAC) and anti...
Main Authors: | Pei-Chun Chen, Gregory Y H Lip, Grace Yeh, Hung-Ju Lin, Kuo-Liong Chien |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0125257 |
Similar Items
-
Antiplatelet Prescription in Atrial Fibrillation: Association with a Low Rate of Anticoagulation
by: Romain Chopard, et al.
Published: (2018-04-01) -
Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants
by: Anne Gulbech Ording, et al.
Published: (2021-07-01) -
Bleeding Complications in Anticoagulated Patients With Atrial Fibrillation and Sepsis: A Propensity‐Weighted Cohort Study
by: Mette Søgaard, et al.
Published: (2017-11-01) -
Prognosis of Atrial Fibrillation Patients Undergoing PCI According to Anticoagulants and Antiplatelet Agents
by: Gwang-Seok Yoon, et al.
Published: (2021-07-01) -
Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS‐BLED and GARFIELD‐AF Bleeding Scores
by: Marco Proietti, et al.
Published: (2018-09-01)